Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176316 · ClinicalTrials.gov registry record · Phase 4
The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus
A Phase 4 study, sponsored by Loyola University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT03176316 is a Phase 4 study that was terminated before completion, run by Loyola University. The registered enrollment target is 53 participants.
The verdict
NCT03176316, a Phase 4 study, was terminated before completion, sponsored by Loyola University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
Postoperative ileus and opioid induced constipation are well-known post-operative complications. Previously, research has shown that using peripherally acting opioid antagonists can help alleviate the condition. There has not been a prospective study to investigate whether use of peripherally acting opioid antagonists are effective in preventing post-operative ileus in patients having spinal fusion surgeries.
Interventions
- DRUG Naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2020-02-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03176316
The ClinicalTrials.gov registry entry for NCT03176316 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naloxone is the first listed.
NCT03176316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03176316 about?
NCT03176316 is a clinical study titled "The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus". Postoperative ileus and opioid induced constipation are well-known post-operative complications. Previously, research has shown that using peripherally acting opioid antagonists can help alleviate the condition. There has not been a prospective study to investigate whether use of peripherally acting...
What is the current status of trial NCT03176316?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2017-09-20. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03176316?
The interventions under investigation include: Naloxone (DRUG).
Who is sponsoring clinical trial NCT03176316?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.